Addex Therapeutics (ADXN) Research & Development (2017 - 2026)
Addex Therapeutics (ADXN) posted Research & Development of -$48.06 million for Q2 2026, compared with -$283.19 million a year earlier.
Powered by 
Analysis
Addex Therapeutics (ADXN) Research & Development (2017 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Research & Development at Addex Therapeutics was -$379.69 million; for FY2025, it was -$840,349.
- In prior years, Addex Therapeutics' Research & Development was -$971,090 in FY2024, -$1.34 million in FY2023, -$8.56 million in FY2022 and -$13.93 million in FY2021.
- Quarterly Research & Development has run from a low of -$285.43 million in Q3 2025 to a high of $5.97 million in Q2 2022 over five years.
- According to Business Quant data, Research & Development for the three prior quarters was -$46.14 million (Q1 2026), -$66,073 (Q4 2025) and -$285.43 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 3.89 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.02 Bn |
| 10 | Addex Therapeutics | 3.65 Mn | -3.31 Mn | - | 48,061.37 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 48,061.37 |
| Mar 31, 2026 | 46.14 Mn |
| Dec 31, 2025 | 66,073.03 |
| Sep 30, 2025 | 285.43 Mn |
| Jun 30, 2025 | 283,194.70 |
| Mar 31, 2025 | 173.58 Mn |
| Dec 31, 2024 | 74,597.31 |
| Sep 30, 2024 | 236.05 Mn |
| Jun 30, 2024 | 375,214.53 |
| Mar 31, 2024 | 280,835.38 |
| Dec 31, 2023 | 168,046.84 |
| Sep 30, 2023 | 555,532.54 |
| Jun 30, 2023 | 2.09 Mn |
| Mar 31, 2023 | 276,094.33 |
| Dec 31, 2022 | -4.19 Mn |
| Sep 30, 2022 | 2.86 Mn |
| Jun 30, 2022 | 5.97 Mn |
| Mar 31, 2022 | 4.08 Mn |
| Dec 31, 2021 | 3.79 Mn |
| Sep 30, 2021 | 3.12 Mn |
API Access
Addex Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ADXN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ADXN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ADXN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();